Metraipolis › archive › dc_29c5a0b201da
Cost-benefit of limited isolation and testing in COVID-19 mitigation — Europe PMC PMID:33122753
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/33122753
- DOI
- 10.1038/s41598-[numero omesso]-2
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T14:51:55.928Z
- SHA-256 of the archived text
b7910d5ac1215195ed508775e625ad7cf2e3e9b710506a0cc1125d632732757b- Stable URL of this page
https://metraipolis.com/documento/dc_29c5a0b201da
How to cite
Cost-benefit of limited isolation and testing in COVID-19 mitigation — Europe PMC PMID:33122753 — Europe PMC (en), https://europepmc.org/article/MED/33122753 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_29c5a0b201da (Metraipolis archive dc_29c5a0b201da, sha256 b7910d5ac1215195ed508775e625ad7cf2e3e9b710506a0cc1125d632732757b)
BibTeX
@misc{dc29c5a0b201da,
title = {Cost-benefit of limited isolation and testing in COVID-19 mitigation — Europe PMC PMID:33122753},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/33122753},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_29c5a0b201da; sha256 b7910d5ac1215195ed508775e625ad7cf2e3e9b710506a0cc1125d632732757b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/33122753. Agents can read the archived copy with the MCP tool read_document.